DEFINITIONS WORKING GROUP: This group was conceived at the 5th HCV DRAG meeting in Boston, 2010 is a collaboration between the HCV DRAG, EASL and AASLD and will help bring uniformity and clarity to the terms and definitions currently being in DAA clinical trials.

Publication:
Wedemeyer H, Jensen DM, Godofsky E, Mani N, Pawlotsky JM, Miller V; Definitions/NomenclatureWorking Group* of the HCV DrAG (HCV Drug Development Advisory Group), under the auspices of the Forum for Collaborative HIV Research. Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents. Hepatology. 2012 Dec;56(6):2398-403.